Why is Sotac Pharma. falling/rising?

As of 11-Jul, Sotac Pharmaceuticals Ltd is currently priced at 129.85, showing no change (0.00%). The stock has underperformed its sector by 0.58% today, despite being higher than the 20-day, 50-day, 100-day, and 200-day moving averages, but lower than the 5-day moving average. Over the past week, the stock has decreased by 4.94%, while it has seen a modest increase of 3.34% over the past month. Notably, the stock has generated a return of -23.17% over the past year, despite a significant profit increase of 79%, which reflects an attractive valuation with a PEG ratio of 0.4. However, there has been a concerning drop in investor participation, with delivery volume falling by 64.29% against the 5-day average.
In the broader market context, the Sensex has declined by 1.22% over the past week, indicating that the stock's short-term performance is worse than the benchmark. While Sotac Pharmaceuticals has outperformed the Sensex with a year-to-date return of 18.80% compared to the benchmark's 6.37%, its long-term performance remains a concern, with a 1-year return significantly lower than the Sensex's 3.43%. This combination of factors suggests that while the stock has potential due to its strong profit growth and attractive valuation metrics, the recent decline in investor participation and overall market conditions may be contributing to its current price stagnation.